Sinclair IS Pharma has agreed to acquire Obvieline Laboratories and certain other distribution rights from Pharmavital for €32.2m. The acquisition of Obvieline gives Sinclair the global rights to Perfectha™ dermal…
Sinclair filling in
Would you like to read this article?
Register below to continue reading this article.
You will be able to read 2 articles. No payment details required.
You will also receive our daily M&A insights email.
There is no obligation to subscribe to the service but we hope that after the trialing your firm will decide to subscribe.
For details of subscription packages or if you are considering a subscription and would like to read a few more articles on your trial, please contact us at subscriptions@acquisitionsdaily.com and we will call you to discuss.
Already a subscriber? Login here
